VV119
/ Vigonvita Life Sci
- LARVOL DELTA
Home
Next
Prev
1 to 6
Of
6
Go to page
1
November 22, 2025
Study of Food Effects of VV119 Capsules in Chinese Healthy Volunteers
(clinicaltrials.gov)
- P1 | N=16 | Not yet recruiting | Sponsor: Vigonvita Life Sciences
New P1 trial
July 29, 2025
Evaluating Safety, Tolerability and Pharmacokinetic of Multiple Ascending Doses of VV119
(clinicaltrials.gov)
- P1 | N=32 | Recruiting | Sponsor: Vigonvita Life Sciences | Trial completion date: Jul 2025 ➔ Dec 2025 | Trial primary completion date: Jul 2025 ➔ Dec 2025
Trial completion date • Trial primary completion date • CNS Disorders • Psychiatry • Schizophrenia
February 12, 2025
Study of the Safety, Tolerability, Pharmacokinetics and Food Effects of VV119 Capsules in Chinese Healthy Volunteers
(clinicaltrials.gov)
- P1 | N=78 | Recruiting | Sponsor: Vigonvita Life Sciences | Trial completion date: Dec 2024 ➔ Dec 2025 | Trial primary completion date: Dec 2024 ➔ Dec 2025
Trial completion date • Trial primary completion date • CNS Disorders • Psychiatry • Schizophrenia
July 31, 2024
Evaluating Safety, Tolerability and Pharmacokinetic of Multiple Ascending Doses of VV119
(clinicaltrials.gov)
- P1 | N=32 | Recruiting | Sponsor: Vigonvita Life Sciences | Not yet recruiting ➔ Recruiting
Enrollment open • CNS Disorders • Psychiatry • Schizophrenia
July 16, 2024
Evaluating Safety, Tolerability and Pharmacokinetic of Multiple Ascending Doses of VV119
(clinicaltrials.gov)
- P1 | N=32 | Not yet recruiting | Sponsor: Vigonvita Life Sciences
New P1 trial • CNS Disorders • Psychiatry • Schizophrenia
May 09, 2024
Study of the Safety, Tolerability, Pharmacokinetics and Food Effects of VV119 Capsules in Chinese Healthy Volunteers
(clinicaltrials.gov)
- P1 | N=78 | Recruiting | Sponsor: Vigonvita Life Sciences | Trial completion date: Apr 2024 ➔ Dec 2024 | Trial primary completion date: Apr 2024 ➔ Dec 2024
Trial completion date • Trial primary completion date • CNS Disorders • Psychiatry • Schizophrenia
1 to 6
Of
6
Go to page
1